vs
Side-by-side financial comparison of BREAD FINANCIAL HOLDINGS, INC. (BFH) and Insulet Corporation (PODD). Click either name above to swap in a different company.
BREAD FINANCIAL HOLDINGS, INC. is the larger business by last-quarter revenue ($975.0M vs $761.7M, roughly 1.3× Insulet Corporation). On growth, Insulet Corporation posted the faster year-over-year revenue change (33.9% vs 5.4%). Over the past eight quarters, Insulet Corporation's revenue compounded faster (24.9% CAGR vs -0.8%).
Bread Financial Holdings, Inc. is an American publicly traded provider of private label credit cards, coalition loyalty programs, and direct marketing, derived from the capture and analysis of transaction-rich data.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
BFH vs PODD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $975.0M | $761.7M |
| Net Profit | — | $91.1M |
| Gross Margin | — | 69.5% |
| Operating Margin | 4.9% | 16.0% |
| Net Margin | — | 12.0% |
| Revenue YoY | 5.4% | 33.9% |
| Net Profit YoY | — | 157.3% |
| EPS (diluted) | $1.21 | $1.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $761.7M | ||
| Q4 25 | $975.0M | $783.7M | ||
| Q3 25 | $971.0M | $706.3M | ||
| Q2 25 | $929.0M | $649.1M | ||
| Q1 25 | $970.0M | $569.0M | ||
| Q4 24 | $925.0M | $597.5M | ||
| Q3 24 | $983.0M | $543.9M | ||
| Q2 24 | $939.0M | $488.5M |
| Q1 26 | — | $91.1M | ||
| Q4 25 | — | $101.6M | ||
| Q3 25 | $188.0M | $87.6M | ||
| Q2 25 | $139.0M | $22.5M | ||
| Q1 25 | $138.0M | $35.4M | ||
| Q4 24 | — | $100.7M | ||
| Q3 24 | $2.0M | $77.5M | ||
| Q2 24 | $133.0M | $188.6M |
| Q1 26 | — | 69.5% | ||
| Q4 25 | — | 72.6% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | — | 71.9% | ||
| Q4 24 | — | 72.1% | ||
| Q3 24 | — | 69.3% | ||
| Q2 24 | — | 67.7% |
| Q1 26 | — | 16.0% | ||
| Q4 25 | 4.9% | 18.7% | ||
| Q3 25 | 20.2% | 16.7% | ||
| Q2 25 | 18.7% | 18.7% | ||
| Q1 25 | 20.3% | 15.6% | ||
| Q4 24 | -2.9% | 18.3% | ||
| Q3 24 | 4.1% | 16.2% | ||
| Q2 24 | 19.2% | 11.2% |
| Q1 26 | — | 12.0% | ||
| Q4 25 | — | 13.0% | ||
| Q3 25 | 19.4% | 12.4% | ||
| Q2 25 | 15.0% | 3.5% | ||
| Q1 25 | 14.2% | 6.2% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | 0.2% | 14.2% | ||
| Q2 24 | 14.2% | 38.6% |
| Q1 26 | — | $1.30 | ||
| Q4 25 | $1.21 | $1.42 | ||
| Q3 25 | $3.96 | $1.24 | ||
| Q2 25 | $2.94 | $0.32 | ||
| Q1 25 | $2.78 | $0.50 | ||
| Q4 24 | $0.08 | $1.38 | ||
| Q3 24 | $0.05 | $1.08 | ||
| Q2 24 | $2.66 | $2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6B | $480.4M |
| Total DebtLower is stronger | $4.3B | $18.6M |
| Stockholders' EquityBook value | $3.3B | $1.3B |
| Total Assets | $22.7B | $3.0B |
| Debt / EquityLower = less leverage | 1.29× | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $480.4M | ||
| Q4 25 | $3.6B | — | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.8B | — | ||
| Q1 25 | $4.2B | — | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $4.1B | — |
| Q1 26 | — | $18.6M | ||
| Q4 25 | $4.3B | $930.8M | ||
| Q3 25 | $3.8B | $934.9M | ||
| Q2 25 | $4.2B | $939.0M | ||
| Q1 25 | $5.1B | $1.6B | ||
| Q4 24 | $5.6B | $1.3B | ||
| Q3 24 | $4.6B | $1.4B | ||
| Q2 24 | — | $1.4B |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $3.3B | $1.5B | ||
| Q3 25 | $3.3B | $1.4B | ||
| Q2 25 | $3.2B | $1.5B | ||
| Q1 25 | $3.1B | $1.3B | ||
| Q4 24 | $3.1B | $1.2B | ||
| Q3 24 | $3.1B | $1.1B | ||
| Q2 24 | $3.2B | $998.4M |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $22.7B | $3.2B | ||
| Q3 25 | $21.7B | $3.0B | ||
| Q2 25 | $21.8B | $3.5B | ||
| Q1 25 | $22.4B | $3.5B | ||
| Q4 24 | $22.9B | $3.1B | ||
| Q3 24 | $21.7B | $3.0B | ||
| Q2 24 | $22.1B | $2.9B |
| Q1 26 | — | 0.01× | ||
| Q4 25 | 1.29× | 0.61× | ||
| Q3 25 | 1.14× | 0.68× | ||
| Q2 25 | 1.34× | 0.64× | ||
| Q1 25 | 1.67× | 1.21× | ||
| Q4 24 | 1.82× | 1.07× | ||
| Q3 24 | 1.47× | 1.21× | ||
| Q2 24 | — | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $568.0M | $113.8M |
| Free Cash FlowOCF − Capex | — | $89.5M |
| FCF MarginFCF / Revenue | — | 11.8% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | — | 1.25× |
| TTM Free Cash FlowTrailing 4 quarters | — | $415.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $113.8M | ||
| Q4 25 | $568.0M | $183.3M | ||
| Q3 25 | $605.0M | $125.7M | ||
| Q2 25 | $526.0M | $196.5M | ||
| Q1 25 | $393.0M | $63.8M | ||
| Q4 24 | $479.0M | $147.7M | ||
| Q3 24 | $456.0M | $98.5M | ||
| Q2 24 | $477.0M | $96.5M |
| Q1 26 | — | $89.5M | ||
| Q4 25 | — | $48.2M | ||
| Q3 25 | — | $100.1M | ||
| Q2 25 | — | $177.9M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $94.1M | ||
| Q3 24 | — | $71.8M | ||
| Q2 24 | — | $74.0M |
| Q1 26 | — | 11.8% | ||
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 14.2% | ||
| Q2 25 | — | 27.4% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | — | 15.7% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 15.1% |
| Q1 26 | — | 3.2% | ||
| Q4 25 | — | 17.2% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 9.0% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 4.6% |
| Q1 26 | — | 1.25× | ||
| Q4 25 | — | 1.80× | ||
| Q3 25 | 3.22× | 1.43× | ||
| Q2 25 | 3.78× | 8.73× | ||
| Q1 25 | 2.85× | 1.80× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | 228.00× | 1.27× | ||
| Q2 24 | 3.59× | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFH
Segment breakdown not available.
PODD
| Omnipod | $515.6M | 68% |
| International Omnipod | $242.9M | 32% |
| Drug Delivery | $3.3M | 0% |
